Synthesis of RP 48497, an impurity of eszopiclone

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its 1H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone. © 2008 by the authors; licensee Molecular Diversity Preservation International.

Author supplied keywords

Cite

CITATION STYLE

APA

Sha, Y., Zhang, L., Du, G. J., Ren, J., & Cheng, M. S. (2008). Synthesis of RP 48497, an impurity of eszopiclone. Molecules, 13(8), 1817–1821. https://doi.org/10.3390/molecules13081817

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free